Literature DB >> 17641698

Central corneal thickness, tonometry, and glaucoma risk--a guide for the perplexed.

James D Brandt1.   

Abstract

The results of the Ocular Hypertension Treatment Study (OHTS) brought to the forefront the role of central corneal thickness (CCT) as a confounder of applanation tonometry, and established CCT as an independent predictive factor for the development of glaucoma. Ophthalmologists often wonder how to use CCT in daily practice. This article reviews the current CCT literature and provides some basic guidance to clinicians wishing to integrate CCT into their care of glaucoma patients.

Entities:  

Mesh:

Year:  2007        PMID: 17641698     DOI: 10.3129/can j ophthalmol.i07-095

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  5 in total

Review 1.  Monitoring Neurodegeneration in Glaucoma: Therapeutic Implications.

Authors:  Norimitsu Ban; Carla J Siegfried; Rajendra S Apte
Journal:  Trends Mol Med       Date:  2017-12-07       Impact factor: 11.951

2.  Combining corneal hysteresis with central corneal thickness and intraocular pressure for glaucoma risk assessment.

Authors:  D Pensyl; M Sullivan-Mee; M Torres-Monte; K Halverson; C Qualls
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

3.  [Recommendations for follow-up examinations in patients with ocular hypertension].

Authors:  M Töteberg-Harms; C Hirn; J Funk
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

4.  Relationship of central corneal thickness to postural IOP changes in patients with and without glaucoma in southern India.

Authors:  Stephen J Moster; Ghasem Fakhraie; Rengaraj Venketesh; Mark L Moster; Yuanjun Zhao; Marlene R Moster
Journal:  Int Ophthalmol       Date:  2012-05-11       Impact factor: 2.031

5.  Prevalence of calibration errors in goldmann applanation tonometers.

Authors:  Heydar Amini; Sasan Moghimi; Mahboobe Golestani; Mahmood Jabbarvand; Reza Zarei; Mohammadreza Esmaili; Zohre Esfandiarpour; Reza Soltani-Moghadam
Journal:  J Ophthalmic Vis Res       Date:  2009-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.